TY - JOUR

T1 - Prevention and adherence in Rheumatic and Musculoskeletal disease

AU - Esbensen, Bente Appel

AU - Kennedy, Norelee

AU - Brodin, Nina

PY - 2020

Y1 - 2020

N2 - Rheumatic and Musculoskeletal Diseases (RMDs) are chronic conditions that affect a substantial number of people. RMDs are significantly related to co-morbidity. Therefore, focusing on prevention in RMDs is of importance to promote and maintain health. Prevention includes primary-, secondary-, tertiary-, and clinical prevention. Primary prevention aims to prevent the onset of disease before the disease process begins, secondary prevention includes detecting and reducing disease and risk factors at the earliest possible point, and tertiary prevention aims to limit the influence of a recognized or verified disease and to address or reduce further development or worsening of the disease, including physical and psychosocial disability. Clinical prevention attempts to integrate prevention into the disease management to limit disease progression and prevent complications and relapse. This chapter will focus on the evidence for prevention and highlight how innovations and trends can contribute by using digital technologies as an example.

AB - Rheumatic and Musculoskeletal Diseases (RMDs) are chronic conditions that affect a substantial number of people. RMDs are significantly related to co-morbidity. Therefore, focusing on prevention in RMDs is of importance to promote and maintain health. Prevention includes primary-, secondary-, tertiary-, and clinical prevention. Primary prevention aims to prevent the onset of disease before the disease process begins, secondary prevention includes detecting and reducing disease and risk factors at the earliest possible point, and tertiary prevention aims to limit the influence of a recognized or verified disease and to address or reduce further development or worsening of the disease, including physical and psychosocial disability. Clinical prevention attempts to integrate prevention into the disease management to limit disease progression and prevent complications and relapse. This chapter will focus on the evidence for prevention and highlight how innovations and trends can contribute by using digital technologies as an example.

KW - Adherence

KW - eHealth

KW - Prevention

KW - Self-management

KW - Telehealth

UR - http://www.scopus.com/inward/record.url?scp=85085143175&partnerID=8YFLogxK

U2 - 10.1016/j.berh.2020.101525

DO - 10.1016/j.berh.2020.101525

M3 - Review

C2 - 32417107

AN - SCOPUS:85085143175

VL - 34

JO - Best Practice & Research: Clinical Rheumatology

JF - Best Practice & Research: Clinical Rheumatology

SN - 1521-6942

IS - 2

M1 - 101525

ER -